Myriad Genetics | MYGN - Sales Revenues


Myriad Genetics reported $190.7M in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Danaher USD 6.3B 350M Jun/2026
Illumina USD 1.16B 70M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Mettler Toledo International USD 1.03B 82.87M Jun/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
OraSure Technologies USD 26.76M 322K Dec/2025
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Quest Diagnostics USD 3.04B 140M Jun/2026
Quidel USD 630.9M 10.9M Jun/2026
Repligen USD 204M 10M Jun/2026
Revvity USD 729.68M 18.68M Jun/2026
Standard Biotools USD 21.1M 2.7M Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Veracyte USD 150.32M 11.25M Jun/2026
Waters USD 1.64B 370M Jun/2026